WebMar 27, 2024 · WATERTOWN, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to improve the lives of ... WebEyePoint Pharmaceuticals has raised a total of $437.9M in funding over 9 rounds. Their latest funding was raised on Mar 9, 2024 from a Post-IPO Debt round. EyePoint …
EyePoint Pharmaceuticals Enters Lease Agreement for the
WebNov 2, 2024 · EyePoint undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Investors: Christina Tartaglia WebEyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome technology ... netflix black earth rising reviews
Sleepy Eye - SouthPoint Financial Credit Union
Web2 days ago · Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Harrow Health To Contact Him Directly To Discuss Their Options. The MarketWatch News ... WebMar 4, 2024 · EyePoint received a one-time $16.5 million payment from SWK in exchange for the rights to future royalties payable to EyePoint from the Alimera agreement. $15 … WebFinancial Information. Financials Overview; Stock Information; Analyst Coverage; Ownership Summary; Annual Reports; Earnings Releases; SEC Filings; Resources. … it\u0027s the dawning of the age of aquarius